Tomaž Bratkovič

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 6

Top Topics

High Throughput

Top Venues

International journal of molecular sciences

Bioconjugate chemistry

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Katja Glinšek, Krištof Bozovičar, Tomaž Bratkovič
CRISPR Technologies in Chinese Hamster Ovary Cell Line Engineering. International journal of molecular sciences 24 (9) (2023)
Katja Glinšek, Krištof Bozovičar, Tomaž Bratkovič
CRISPR Technologies in Chinese Hamster Ovary Cell Line Engineering. International journal of molecular sciences 24 (9) (2023)
Ana Dolšak, Tomaž Bratkovič, Larisa Mlinarič, Eva Ogorevc, Urban Švajger, Stanislav Gobec, Matej Sova
Novel Selective IDO1 Inhibitors with Isoxazolo[5,4-d]pyrimidin-4(5H)-one Scaffold. Pharmaceuticals (Basel, Switzerland) 14 (3) (2021)
Krištof Bozovičar, Tomaž Bratkovič
Small and Simple, yet Sturdy: Conformationally Constrained Peptides with Remarkable Properties. International journal of molecular sciences 22 (4) (2021)
Nika Kruljec, Peter Molek, Vesna Hodnik, Gregor Anderluh, Tomaž Bratkovič
Development and Characterization of Peptide Ligands of Immunoglobulin G Fc Region. Bioconjugate chemistry 29 (8) (2018)
Nika Kruljec, Tomaž Bratkovič
Alternative Affinity Ligands for Immunoglobulins. Bioconjugate chemistry 28 (8) (2017)